Ginsenoside Rb1 from Panax notoginseng Suppressed TNF-α-Induced Matrix Metalloproteinase-9 via the Suppression of

Wen-Tao Sun1, Cindy L H Yang2, Terry C T Or2

  • 1School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao 266071, China.

Insights

Ginsenoside Rb1 from Panax notoginseng inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 (MMP-9) production. This compound shows potential for treating inflammatory conditions and cancer metastasis.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Traditional Chinese Medicine

Background:

  • Chronic inflammation stimulates matrix metalloproteinases (MMPs), leading to extracellular matrix degradation.
  • Overexpression of MMP-9 (Gelatinase B) is implicated in cardiac remodeling and liver cancer metastasis.
  • Panax notoginseng (Sanqi) is a traditional Chinese herb with known myocardial protective and anti-tumor properties.

Purpose of the Study:

  • To investigate the inhibitory effects of Panax notoginseng extracts on tumor necrosis factor-α (TNF-α)-induced MMP-9 expression.
  • To identify the active compound responsible for MMP-9 inhibition.
  • To explore the therapeutic potential of the identified compound in inflammatory and metastatic conditions.

Main Methods:

  • Bioassay-guided fractionation of Panax notoginseng extracts.
  • Silica gel column chromatography and high-performance liquid chromatography for compound isolation.
  • Identification of the active compound using nuclear magnetic resonance spectroscopy.
  • Assay of MMP-9 production in H9c2 and HepG-2 cells stimulated with TNF-α.

Main Results:

  • Ginsenoside Rb1 was isolated and identified as the active compound.
  • Ginsenoside Rb1 significantly inhibited TNF-α-induced MMP-9 production in both cardiac myoblast H9c2 and liver carcinoma HepG-2 cells.
  • Ginsenoside Rb1 did not affect MMP-2 levels or cell proliferation in either cell line.
  • Inhibitory effects are potentially mediated by modulation of protein kinase and nuclear factor kappa B signaling pathways.

Conclusions:

  • Ginsenoside Rb1 demonstrates potent inhibition of MMP-9 production.
  • This suggests a potential therapeutic role for Ginsenoside Rb1 in managing inflammatory diseases and preventing metastasis of hepatocellular carcinomas.
  • Further research into its signaling pathway modulation could elucidate its mechanisms of action.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K